BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32416273)

  • 21. Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
    He Y; Wang Y; Zhou R; Wang J
    Int J Gynecol Cancer; 2020 Dec; 30(12):1902-1907. PubMed ID: 33051245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservative management of early-stage endometrial cancer for fertility preservation: a survey study among Swedish gynecologists and gynecological oncologists.
    Iliadis SI; Gambadauro P
    Sci Rep; 2023 Apr; 13(1):5861. PubMed ID: 37041242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience.
    Wang Y; Yu M; Yang JX; Cao DY; Yuan Z; Zhou HM; Zhang Y; Li L; Shen K; Wu H
    Int J Clin Oncol; 2019 Jun; 24(6):712-720. PubMed ID: 30746595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.
    Hirata T; Kondo E; Magawa S; Kubo-Kaneda M; Nii M; Yoshida K; Maezawa T; Tabata T; Ikeda T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3219-3225. PubMed ID: 36054237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia.
    Harrison RF; He W; Fu S; Zhao H; Sun CC; Suidan RS; Woodard TL; Rauh-Hain JA; Westin SN; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Nov; 221(5):474.e1-474.e11. PubMed ID: 31128110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: A single-center experience.
    Ayhan A; Tohma YA; Tunc M
    Taiwan J Obstet Gynecol; 2020 May; 59(3):415-419. PubMed ID: 32416890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
    Xi Y; Liu G; Liu D; Jiang J; Gong R
    Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review.
    Murakami I; Machida H; Morisada T; Terao Y; Tabata T; Mikami M; Hirashima Y; Kobayashi Y; Baba T; Nagase S
    J Gynecol Oncol; 2023 Jul; 34(4):e49. PubMed ID: 36929578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Little information about fertility preservation is provided for cancer patients: A survey of oncologists' knowledge, attitude and current practice.
    Vesali S; Navid B; Mohammadi M; Karimi E; Omani-Samani R
    Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12947. PubMed ID: 30421553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservative management of endometrial cancer: a survey amongst European clinicians.
    La Russa M; Zapardiel I; Halaska MJ; Zalewski K; Laky R; Dursun P; Lindquist D; Sukhin V; Polterauer S; Biliatis I
    Arch Gynecol Obstet; 2018 Aug; 298(2):373-380. PubMed ID: 29943129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hysteroscopy and weight loss in treatment of endometrial cancer: case report and literature review.
    Gallo A; D'alisa R; Di Spiezio Sardo A; Guerra S; Berardi G; Vitale SG; Palumbo M; Cretella P; Angioni S; Bifulco G; Musella M
    Minim Invasive Ther Allied Technol; 2024 Apr; 33(2):109-119. PubMed ID: 38108527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review.
    Piatek S; Michalski W; Sobiczewski P; Bidzinski M; Szewczyk G
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():139-147. PubMed ID: 34214800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
    Cholakian D; Hacker K; Fader AN; Gehrig PA; Tanner EJ
    Gynecol Oncol; 2016 Feb; 140(2):234-8. PubMed ID: 26706662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fertility sparing management of endometrial adenocarcinoma and atypical hyperplasia: a literature review].
    Koskas M; Yazbeck C; Walker F; Delorme P; Azria E; Luton D; Madelenat P
    Bull Cancer; 2012 Jan; 99(1):51-60. PubMed ID: 22212645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
    Guillon S; Popescu N; Phelippeau J; Koskas M
    Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
    Pashov AI; Tskhay VB; Ionouchene SV
    Gynecol Endocrinol; 2012 Jul; 28(7):559-61. PubMed ID: 22296608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility-sparing approach for endometrial cancer: the role of office hysteroscopy.
    Carugno J; Wong A
    Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):296-303. PubMed ID: 34292797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of hysteroscopic surgery combined with progesterone therapy on fertility and prognosis in patients with early endometrial cancer and atypical endometrial hyperplasia or endometrial intraepithelial neoplasia: a meta-analysis.
    Ye X; Li T
    Arch Gynecol Obstet; 2024 Jan; 309(1):259-268. PubMed ID: 37540307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.